Trial intelligence / Profile preview

Perioperative etoricoxib versus diclofenac after total hip arthroplasty

2009-015383-33Phase 4Completed

Sponsor
University of Regensburg
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, double-blind trial of etoricoxib and diclofenac in hip osteoarthritis (2 arms), sponsored by University of Regensburg. Primary endpoint: Total perioperative blood loss. Started Jun 2010; status: completed.

02

Drugs

etoricoxibdiclofenac
03

Conditions

hip osteoarthritis

Beyond the preview

Go deeper on 2009-015383-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015383-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call